[go: up one dir, main page]

PE20120220A1 - Macrolido anti-inflamatorio - Google Patents

Macrolido anti-inflamatorio

Info

Publication number
PE20120220A1
PE20120220A1 PE2011001406A PE2011001406A PE20120220A1 PE 20120220 A1 PE20120220 A1 PE 20120220A1 PE 2011001406 A PE2011001406 A PE 2011001406A PE 2011001406 A PE2011001406 A PE 2011001406A PE 20120220 A1 PE20120220 A1 PE 20120220A1
Authority
PE
Peru
Prior art keywords
theta
grades
peaks
presents
xrpd pattern
Prior art date
Application number
PE2011001406A
Other languages
English (en)
Inventor
Caroline Jane Day
Julien Bruno Douillet
Darko Filic
Leanda Jane Kindon
Goran Kragol
Zorica Marusic-Istuk
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20120220(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20120220A1 publication Critical patent/PE20120220A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE REFIERE AL COMPUESTO 3'-N-DESMETIL-4"-O-(2-DIETILAMINOETANOIL)-6-O-METIL-9A-AZA-9A-HOMOERITROMICINA A Y A FORMAS CRISTALINAS DEL MISMO TAL COMO: A) LA FORMA 1 CRISTALINA CUYO PATRON DE XRPD EXPRESADO EN GRADOS 2 THETA PRESENTA LOS PICOS 4.6, 5.6, 7.7, 9.6, 10.6, 11.0, 11.6, 11.8, 12.2, 14.1, 15.9, 18.4, 19.0, 20.5, 21.1 Y 22.0; B) LA FORMA 2 CRISTALINA CUYO PATRON DE XRPD EXPRESADO EN GRADOS 2 THETA PRESENTA LOS PICOS 9.1, 9.4, 10.4, 10.9, 11.5, 12.0, 13.0, 13.4, 14.7, 15.4, 15.7, 16.5, 16.8, 18.7, 19.2, 19.5, 19.8 Y 20.8; Y C) LA FORMA 3 CRISTALINA CUYO PATRON DE XRPD EXPRESADO EN GRADOS 2 THETA PRESENTA LOS PICOS 5.5, 7.3, 7.9, 9.1, 9.5, 10.0, 10.5, 11.0, 11.5, 12.0, 12.6, 14.8, 15.5, 15.8, 16.6, 16.9, 18.2, 18.9 Y 19.5. TAMBIEN SE REFIERE A UN PROCESO DE OBTENCION. DICHO COMPUESTO ES UTIL EN EL TRATAMIENTO DE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, FIBROSIS QUISTICA, BRONQUITIS, ENFISEMA, ASMA
PE2011001406A 2009-01-30 2010-01-28 Macrolido anti-inflamatorio PE20120220A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14860909P 2009-01-30 2009-01-30

Publications (1)

Publication Number Publication Date
PE20120220A1 true PE20120220A1 (es) 2012-04-04

Family

ID=41698466

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001406A PE20120220A1 (es) 2009-01-30 2010-01-28 Macrolido anti-inflamatorio

Country Status (23)

Country Link
US (1) US8227428B2 (es)
EP (1) EP2384333B1 (es)
JP (1) JP5437394B2 (es)
KR (1) KR20110099791A (es)
CN (1) CN102378763A (es)
AR (1) AR075340A1 (es)
AU (1) AU2010209732B2 (es)
BR (1) BRPI1006114A2 (es)
CA (1) CA2748847A1 (es)
CL (1) CL2011001829A1 (es)
CO (1) CO6400226A2 (es)
DO (1) DOP2011000242A (es)
EA (1) EA201101139A1 (es)
ES (1) ES2412059T3 (es)
IL (1) IL213871A0 (es)
MA (1) MA32997B1 (es)
MX (1) MX2011008074A (es)
PE (1) PE20120220A1 (es)
SG (1) SG172782A1 (es)
TW (1) TW201038277A (es)
UY (1) UY32408A (es)
WO (1) WO2010086349A1 (es)
ZA (1) ZA201104653B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS51479B (en) 2005-01-13 2011-04-30 Glaxo Group Limited MACROLIDES WITH ANTI-INFLAMMATORY ACTION
UY32408A (es) 2009-01-30 2010-07-30 Glaxo Group Ltd Macrolido anti-inflamatorio
WO2011116312A1 (en) * 2010-03-19 2011-09-22 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
WO2011131749A1 (en) * 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
JP6116206B2 (ja) * 2012-11-26 2017-04-19 クリニプロ株式会社 吸入用パウダーの製造方法
RU2742417C1 (ru) * 2017-01-13 2021-02-05 Тобиси Фармасьютикал Ко., Лтд. Регулятор активации нейтрофилов

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US525051A (en) 1894-08-28 Adjustable chair
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
AU610160B2 (en) * 1987-05-06 1991-05-16 Adir Et Compagnie New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HRP980189B1 (en) 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
KR100474229B1 (ko) * 1999-05-18 2005-03-08 화이자 프로덕츠 인크. 마크롤라이드계 항생제의 신규 결정형
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2317527T3 (es) 2005-01-13 2009-04-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
RS51479B (en) * 2005-01-13 2011-04-30 Glaxo Group Limited MACROLIDES WITH ANTI-INFLAMMATORY ACTION
WO2006106440A1 (en) 2005-01-14 2006-10-12 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolide compounds containing biotin and photo-affinity group for macrolide target identification
UY32408A (es) 2009-01-30 2010-07-30 Glaxo Group Ltd Macrolido anti-inflamatorio

Also Published As

Publication number Publication date
DOP2011000242A (es) 2011-09-15
JP2012516304A (ja) 2012-07-19
US20100197623A1 (en) 2010-08-05
UY32408A (es) 2010-07-30
CL2011001829A1 (es) 2011-10-14
TW201038277A (en) 2010-11-01
CO6400226A2 (es) 2012-03-15
EP2384333A1 (en) 2011-11-09
AR075340A1 (es) 2011-03-23
ZA201104653B (en) 2012-02-29
KR20110099791A (ko) 2011-09-08
AU2010209732B2 (en) 2012-12-20
US8227428B2 (en) 2012-07-24
EP2384333B1 (en) 2013-04-17
EA201101139A1 (ru) 2012-03-30
JP5437394B2 (ja) 2014-03-12
ES2412059T3 (es) 2013-07-10
MX2011008074A (es) 2011-08-17
CA2748847A1 (en) 2010-08-05
IL213871A0 (en) 2011-07-31
BRPI1006114A2 (pt) 2018-02-06
MA32997B1 (fr) 2012-01-02
CN102378763A (zh) 2012-03-14
SG172782A1 (en) 2011-08-29
WO2010086349A1 (en) 2010-08-05
AU2010209732A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
PE20120220A1 (es) Macrolido anti-inflamatorio
UA115143C2 (uk) Установка з вироблення сечовини
CL2008001982A1 (es) Acido (2s)-2-{[3´-cloro-4´-[2,2-dimetilpirrolidin-1-il) carbonil]-5-fluorobifenil-2-il]oxi}propanoico y su sal 2-metilpropan-2-amina; formas cristalinas de la sal y del acido libre; compuestos intermediarios; y uso en el tratamiento de asma, rinitis y enfermedad pulmonar obstructiva cronica.
ECSP088741A (es) Derivados de benzotriazol como agonistas del adrenoreceptor beta2
BR112015014178A2 (pt) compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
AR086745A1 (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CO6290676A2 (es) Recuperacion de alcoholes superiores a partir de soluciones acuosas diluidas
CL2012001480A1 (es) Sal cristalina anhidra del acido monofosforico de 3-(2,6-dicloro-3,5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea, forma a y b; metodo de preparacion; composicion farmaceutica; y su uso en el tratamiento de carcinomas, psoriasis, entre otras.
UY29672A1 (es) Nuevos derivados de pirazina
CO6491074A2 (es) Recuperacion de alcoholes superiores a partir de soluciones acuosas diluidas
JP2009501689A5 (es)
WO2010088243A3 (en) Processes using molecular sieve ssz-79
EP2138505A4 (en) METHOD FOR PRODUCING HIGH-PURITY SOLUBLE THROMBOMODULINE
BRPI0809942A2 (pt) Processo de derivados de porfirina, tal como a protoporfirina (ix) e intermediário de síntese
BR112015014062A2 (pt) compostos bloqueadores do canal de sódio epitelial arilalquil- e ariloxialquil-substituídos
BRPI0917069A2 (pt) Processo de produção de etanol a partir de algodão têxtil
BRPI0814013A2 (pt) material refratário disforme, um processo para a produção de um material refratário disforme de consistência de terra úmida, bem como o uso do material refratário amorfo
WO2010079981A3 (ko) 탄소나노튜브의 정제 방법 및 분산 방법
ITAN20130155A1 (it) Procedimento per la realizzazione di un pannello isolante termoacustico e pannello realizzato con detto procedimento.
TH93122B (th) กระเบื้องมุงหลังคา
TH138624S (th) ยางรถจักรยาน
Tiwari et al. Reduction in analogue generation during Actinomycetes fermentation
TH38164S1 (th) โต๊ะ
TH113152S (th) โต๊ะ
TH48337S1 (th) ตัวล็อค

Legal Events

Date Code Title Description
FD Application declared void or lapsed